APO Research
Talk to an analyst

APO RESEARCH · REPORT

Melanin Concentrating Hormone Receptor 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Melanin Concentrating Hormone Receptor 1 Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchMelanin Concentrating Hormone Receptor 1 Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Melanin Concentrating Hormone Receptor 1 Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Melanin Concentrating Hormone Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Melanin Concentrating Hormone Receptor 1 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Melanin Concentrating Hormone Receptor 1 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Melanin Concentrating Hormone Receptor 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Melanin Concentrating Hormone Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Melanin Concentrating Hormone Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Melanin Concentrating Hormone Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Melanin Concentrating Hormone Receptor 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Melanin Concentrating Hormone Receptor 1 market include Boehringer Ingelheim GmbH, ConSynance Therapeutics Inc, AstraZeneca Plc and Takeda Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Melanin Concentrating Hormone Receptor 1 market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Melanin Concentrating Hormone Receptor 1 and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Melanin Concentrating Hormone Receptor 1 revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Melanin Concentrating Hormone Receptor 1 market.

Melanin Concentrating Hormone Receptor 1 Segment by Company

Boehringer Ingelheim GmbH

ConSynance Therapeutics Inc

AstraZeneca Plc

Takeda Pharmaceutical Co Ltd

Melanin Concentrating Hormone Receptor 1 Segment by Type

BI-186908

AZD-3857

AZ-13483342

ALB-127158(a)

Others

Melanin Concentrating Hormone Receptor 1 Segment by Application

Inflammatory Bowel Disease

Obesity

Non-Alcoholic Steatohepatitis

Others

Melanin Concentrating Hormone Receptor 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Melanin Concentrating Hormone Receptor 1 status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Melanin Concentrating Hormone Receptor 1 key companies, revenue, market share, and recent developments.

3. To split the Melanin Concentrating Hormone Receptor 1 breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Melanin Concentrating Hormone Receptor 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Melanin Concentrating Hormone Receptor 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Melanin Concentrating Hormone Receptor 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melanin Concentrating Hormone Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melanin Concentrating Hormone Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melanin Concentrating Hormone Receptor 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Melanin Concentrating Hormone Receptor 1 industry.

Chapter 3: Detailed analysis of Melanin Concentrating Hormone Receptor 1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Melanin Concentrating Hormone Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Melanin Concentrating Hormone Receptor 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Melanin Concentrating Hormone Receptor 1 Industry Trends Table 2. Melanin Concentrating Hormone Receptor 1 Industry Drivers Table 3. Melanin Concentrating Hormone Receptor 1 Industry Opportunities and Challenges Table 4. Melanin Concentrating Hormone Receptor 1 Industry Restraints Table 5. Global Melanin Concentrating Hormone Receptor 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Melanin Concentrating Hormone Receptor 1 Revenue Share by Company (2021-2026) Table 7. Global Melanin Concentrating Hormone Receptor 1 Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Melanin Concentrating Hormone Receptor 1 Key Company Manufacturing Base & Headquarters Table 9. Global Melanin Concentrating Hormone Receptor 1 Company, Product Type & Application Table 10. Global Melanin Concentrating Hormone Receptor 1 Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Melanin Concentrating Hormone Receptor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of BI-186908 Table 15. Significant Companies of AZD-3857 Table 16. Significant Companies of AZ-13483342 Table 17. Significant Companies of ALB-127158(a) Table 18. Significant Companies of Others Table 19. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type (2021-2026) Table 23. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Inflammatory Bowel Disease Table 25. Significant Companies of Obesity Table 26. Significant Companies of Non-Alcoholic Steatohepatitis Table 27. Significant Companies of Others Table 28. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application (2021-2026) Table 32. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application (2027-2032) Table 33. Global Melanin Concentrating Hormone Receptor 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Region (2021-2026) Table 36. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Region (2027-2032) Table 38. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Melanin Concentrating Hormone Receptor 1 Sales Value Market Share by Country (2021-2026) Table 41. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Melanin Concentrating Hormone Receptor 1 Sales Value Market Share by Country (2027-2032) Table 43. Boehringer Ingelheim GmbH Company Information Table 44. Boehringer Ingelheim GmbH Business Overview Table 45. Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 47. Boehringer Ingelheim GmbH Recent Development Table 48. ConSynance Therapeutics Inc Company Information Table 49. ConSynance Therapeutics Inc Business Overview Table 50. ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 52. ConSynance Therapeutics Inc Recent Development Table 53. AstraZeneca Plc Company Information Table 54. AstraZeneca Plc Business Overview Table 55. AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 57. AstraZeneca Plc Recent Development Table 58. Takeda Pharmaceutical Co Ltd Company Information Table 59. Takeda Pharmaceutical Co Ltd Business Overview Table 60. Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 62. Takeda Pharmaceutical Co Ltd Recent Development Table 63. Research Programs/Design for This Report Table 64. Authors List of This Report Table 65. Secondary Sources Table 66. Primary Sources List of Figures Figure 1. Melanin Concentrating Hormone Receptor 1 Product Image Figure 2. Global Melanin Concentrating Hormone Receptor 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melanin Concentrating Hormone Receptor 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Melanin Concentrating Hormone Receptor 1 Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. BI-186908 Image Figure 8. AZD-3857 Image Figure 9. AZ-13483342 Image Figure 10. ALB-127158(a) Image Figure 11. Others Image Figure 12. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type (2021-2032) Figure 15. Inflammatory Bowel Disease Image Figure 16. Obesity Image Figure 17. Non-Alcoholic Steatohepatitis Image Figure 18. Others Image Figure 19. Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application (2021-2032) Figure 22. Global Melanin Concentrating Hormone Receptor 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 25. North America Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 31. South America Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • BI-186908
  • AZD-3857
  • AZ-13483342
  • ALB-127158(a)
  • Others
Applications
  • Inflammatory Bowel Disease
  • Obesity
  • Non-Alcoholic Steatohepatitis
  • Others
Companies covered
  • Boehringer Ingelheim GmbH
  • ConSynance Therapeutics Inc
  • AstraZeneca Plc
  • Takeda Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Melanin Concentrating Hormone Receptor 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Melanin Concentrating Hormone Receptor 1 Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Melanin Concentrating Hormone Receptor 1 Market Dynamics
  1. 2.1 Melanin Concentrating Hormone Receptor 1 Industry Trends
  2. 2.2 Melanin Concentrating Hormone Receptor 1 Industry Drivers
  3. 2.3 Melanin Concentrating Hormone Receptor 1 Industry Opportunities and Challenges
  4. 2.4 Melanin Concentrating Hormone Receptor 1 Industry Restraints
3 Melanin Concentrating Hormone Receptor 1 Market by Company
  1. 3.1 Global Melanin Concentrating Hormone Receptor 1 Company Revenue Ranking in 2025
  2. 3.2 Global Melanin Concentrating Hormone Receptor 1 Revenue by Company (2021-2026)
  3. 3.3 Global Melanin Concentrating Hormone Receptor 1 Company Ranking (2024-2026)
  4. 3.4 Global Melanin Concentrating Hormone Receptor 1 Company Manufacturing Base and Headquarters
  5. 3.5 Global Melanin Concentrating Hormone Receptor 1 Company Product Type and Application
  6. 3.6 Global Melanin Concentrating Hormone Receptor 1 Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Melanin Concentrating Hormone Receptor 1 Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Melanin Concentrating Hormone Receptor 1 Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Melanin Concentrating Hormone Receptor 1 Market by Type
  1. 4.1 Melanin Concentrating Hormone Receptor 1 Type Introduction
  2. 4.1.1 BI-186908
  3. 4.1.2 AZD-3857
  4. 4.1.3 AZ-13483342
  5. 4.1.4 ALB-127158(a)
  6. 4.1.5 Others
  7. 4.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type
  8. 4.2.1 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Type (2021-2032)
  10. 4.2.3 Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type (2021-2032)
5 Melanin Concentrating Hormone Receptor 1 Market by Application
  1. 5.1 Melanin Concentrating Hormone Receptor 1 Application Introduction
  2. 5.1.1 Inflammatory Bowel Disease
  3. 5.1.2 Obesity
  4. 5.1.3 Non-Alcoholic Steatohepatitis
  5. 5.1.4 Others
  6. 5.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application
  7. 5.2.1 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Application (2021-2032)
  9. 5.2.3 Global Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application (2021-2032)
6 Melanin Concentrating Hormone Receptor 1 Regional Value Analysis
  1. 6.1 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Region (2021-2032)
  3. 6.2.1 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Region: 2021-2026
  4. 6.2.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032)
  7. 6.3.2 North America Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032)
  10. 6.4.2 Europe Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032)
  16. 6.6.2 South America Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Melanin Concentrating Hormone Receptor 1 Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Melanin Concentrating Hormone Receptor 1 Sales Value Share by Country, 2025 VS 2032
7 Melanin Concentrating Hormone Receptor 1 Country-level Value Analysis
  1. 7.1 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country (2021-2032)
  3. 7.2.1 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country (2021-2026)
  4. 7.2.2 Global Melanin Concentrating Hormone Receptor 1 Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Melanin Concentrating Hormone Receptor 1 Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Melanin Concentrating Hormone Receptor 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Melanin Concentrating Hormone Receptor 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim GmbH
  2. 8.1.1 Boehringer Ingelheim GmbH Company Information
  3. 8.1.2 Boehringer Ingelheim GmbH Business Overview
  4. 8.1.3 Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Product Portfolio
  6. 8.1.5 Boehringer Ingelheim GmbH Recent Developments
  7. 8.2 ConSynance Therapeutics Inc
  8. 8.2.1 ConSynance Therapeutics Inc Company Information
  9. 8.2.2 ConSynance Therapeutics Inc Business Overview
  10. 8.2.3 ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Product Portfolio
  12. 8.2.5 ConSynance Therapeutics Inc Recent Developments
  13. 8.3 AstraZeneca Plc
  14. 8.3.1 AstraZeneca Plc Company Information
  15. 8.3.2 AstraZeneca Plc Business Overview
  16. 8.3.3 AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Product Portfolio
  18. 8.3.5 AstraZeneca Plc Recent Developments
  19. 8.4 Takeda Pharmaceutical Co Ltd
  20. 8.4.1 Takeda Pharmaceutical Co Ltd Company Information
  21. 8.4.2 Takeda Pharmaceutical Co Ltd Business Overview
  22. 8.4.3 Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Product Portfolio
  24. 8.4.5 Takeda Pharmaceutical Co Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst